C-HZUXPAI-1 inhibition, anti-fibrotic therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Patents are split by ownership. Held by the company are assigned to this organization. Field corridor patents are held by others in the same technical area — shown to map the freedom-to-operate landscape, not company-owned IP.
Patents assigned to this organization.
US20030065124A1 - High performance polyurethane elastomers from MDI prepolymers with reduced content of free MDI monomer - Google Patents US20030065124A1 - High performance polyurethane elastomers from MDI prepolymers with reduced content o…
WO2018182912A1 - A novel mdi-based prepolymer binder for moisture curing binder application - Google Patents WO2018182912A1 - A novel mdi-based prepolymer binder for moisture curing binder application - Google Patents A novel mdi-based prep…
US8142763B2 - Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining - Google Patent…
WO2022029289A1 - Caprolactam-modified liquid mdi and its use in polyurethanes - Google Patents WO2022029289A1 - Caprolactam-modified liquid mdi and its use in polyurethanes - Google Patents Caprolactam-modified liquid mdi and its use in pol…
US8906975B1 - Conventional flexible polyurethane foam using MDI - Google Patents US8906975B1 - Conventional flexible polyurethane foam using MDI - Google Patents Conventional flexible polyurethane foam using MDI Download PDF Info Publicatio…
CA2392045C - High performance polyurethane elastomers from mdi prepolymers with reduced content of free mdi monomer - Google Patents CA2392045C - High performance polyurethane elastomers from mdi prepolymers with reduced content of free mdi…
CN103665316A - Preparation method of organic silicon modified MDI - Google Patents CN103665316A - Preparation method of organic silicon modified MDI - Google Patents Preparation method of organic silicon modified MDI Download PDF Info Publi…
US6127463A - Polymeric MDI color reduction - Google Patents US6127463A - Polymeric MDI color reduction - Google Patents Polymeric MDI color reduction Download PDF Info Publication number US6127463A US6127463A US09/274,405 US27440599A US6127…
US6884904B2 - MDI-based polyurethane prepolymer with low monomeric MDI content - Google Patents US6884904B2 - MDI-based polyurethane prepolymer with low monomeric MDI content - Google Patents MDI-based polyurethane prepolymer with low monom…
US20080146765A1 - High performance polyurethane elastomers from mdi prepolymers with reduced content of free mdi monomer - Google Patents US20080146765A1 - High performance polyurethane elastomers from mdi prepolymers with reduced content o…
Blocking or adjacent IP in the same technical area, owned by third parties. Not affiliated with this organization.
US20200297854A1 - Nanotherapeutics for drug targeting - Google Patents US20200297854A1 - Nanotherapeutics for drug targeting - Google Patents Nanotherapeutics for drug targeting Download PDF Info Publication number US20200297854A1 US2020029…
WO2021066062A1 - 免疫チェックポイント分子の発現抑制剤 - Google Patents WO2021066062A1 - 免疫チェックポイント分子の発現抑制剤 - Google Patents 免疫チェックポイント分子の発現抑制剤 Download PDF Info Publication number WO2021066062A1 WO2021066062A1 PCT/JP2020/037285 JP2020037285W WO2021066062A1 W…
US10273236B2 - Macrocyclic factor XIa inhibitors bearing heterocyclic groups - Google Patents US10273236B2 - Macrocyclic factor XIa inhibitors bearing heterocyclic groups - Google Patents Macrocyclic factor XIa inhibitors bearing heterocycl…
WO2013056034A1 - Substituted tetrahydroisoquinoline compounds as factor xia inhibitors - Google Patents WO2013056034A1 - Substituted tetrahydroisoquinoline compounds as factor xia inhibitors - Google Patents Substituted tetrahydroisoquinoli…
WO2019018571A1 - Methods and uses of inflammatory bowel disease biomarkers - Google Patents WO2019018571A1 - Methods and uses of inflammatory bowel disease biomarkers - Google Patents Methods and uses of inflammatory bowel disease biomarker…
US11137409B2 - Identification of novel disease states using viscoelastic analysis in the presence of a thrombolytic agent - Google Patents US11137409B2 - Identification of novel disease states using viscoelastic analysis in the presence of…
WO2010113022A1 - Plasminogen activator inhibitor-1 inhibitor - Google Patents WO2010113022A1 - Plasminogen activator inhibitor-1 inhibitor - Google Patents Plasminogen activator inhibitor-1 inhibitor Download PDF Info Publication number WO2…
US8415479B2 - Inhibitor of plasminogen activator inhibitor-1 - Google Patents US8415479B2 - Inhibitor of plasminogen activator inhibitor-1 - Google Patents Inhibitor of plasminogen activator inhibitor-1 Download PDF Info Publication number…
EP3641888B1 - Plasminogen treatment of conditions associated with pai-1 overexpression - Google Patents EP3641888B1 - Plasminogen treatment of conditions associated with pai-1 overexpression - Google Patents Plasminogen treatment of conditi…
WO2001051085A1 - Antagonistes de l'inhibiteur de type 1 des activateurs du plasminogene (pai-1) destines au traitement de l'asthme et de maladies respiratoires obstructives chroniques - Google Patents WO2001051085A1 - Antagonistes d…
US10689376B2 - Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeut…
JP2017533721A5 - - Google Patents JP2017533721A5 - - Google Patents Download PDF Info Publication number JP2017533721A5 JP2017533721A5 JP2017525921A JP2017525921A JP2017533721A5 JP 2017533721 A5 JP2017533721 A5 JP 2017533721A5 JP 2017525921…
WO2020115508A1 - Therapeutic hydrogel compositions - Google Patents WO2020115508A1 - Therapeutic hydrogel compositions - Google Patents Therapeutic hydrogel compositions Download PDF Info Publication number WO2020115508A1 WO2020115508A1 PCT…
US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5-targeted FAP-CAR T mRNA-LNP - Google Patents US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5-targeted FAP-CAR T mRNA-LNP - Google Patents In vivo targeting of Fibrosis…
US11022608B2 - Compositions and methods for detecting and treating pathological fibroblast cells - Google Patents US11022608B2 - Compositions and methods for detecting and treating pathological fibroblast cells - Google Patents Compositions…
WO2016140714A1 - Novel compositions and uses of metformin agents - Google Patents WO2016140714A1 - Novel compositions and uses of metformin agents - Google Patents Novel compositions and uses of metformin agents Download PDF Info Publicatio…
US11230606B2 - Anti-pro-N-cadherin antibodies and methods of treating pathological fibrotic conditions and tumor cells - Google Patents US11230606B2 - Anti-pro-N-cadherin antibodies and methods of treating pathological fibrotic conditions a…
US20250011405A1 - Treatment and diagnosis of diseases associated to pathogenic fibrosis - Google Patents US20250011405A1 - Treatment and diagnosis of diseases associated to pathogenic fibrosis - Google Patents Treatment and diagnosis of dis…
WO2022104289A1 - Use of pharmaceutical doses of niacin, or an analog thereof, for the regression or reversal of fibrosis and/or liver cirrhosis - Google Patents WO2022104289A1 - Use of pharmaceutical doses of niacin, or an analog thereof, f…
WO2012162592A1 - Pirfenidone and anti-fibrotic therapy in selected patients - Google Patents WO2012162592A1 - Pirfenidone and anti-fibrotic therapy in selected patients - Google Patents Pirfenidone and anti-fibrotic therapy in selected pati…